Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease

被引:130
作者
Goldberg, Joshua A. [1 ]
Guzman, Jaime N. [1 ]
Estep, Chad M. [1 ]
Ilijic, Ema [1 ]
Kondapalli, Jyothisri [1 ]
Sanchez-Padilla, Javier [1 ]
Surmeier, D. James [1 ]
机构
[1] NW Univ Chicago, Feinberg Sch Med, Dept Physiol, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
DORSAL MOTOR NUCLEUS; CHANNEL BLOCKERS; I-H; CA2+; HYPERPOLARIZATION; PACEMAKING; CURRENTS; VAGUS;
D O I
10.1038/nn.3209
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Mitochondrial oxidant stress is widely viewed as being critical to pathogenesis in Parkinson's disease. But the origins of this stress are poorly defined. One possibility is that it arises from the metabolic demands associated with regenerative activity. To test this hypothesis, we characterized neurons in the dorsal motor nucleus of the vagus (DMV), a population of cholinergic neurons that show signs of pathology in the early stages of Parkinson's disease, in mouse brain slices. DMV neurons were slow, autonomous pacemakers with broad spikes, leading to calcium entry that was weakly buffered. Using a transgenic mouse expressing a redox-sensitive optical probe targeted to the mitochondrial matrix, we found that calcium entry during pacemaking created a basal mitochondrial oxidant stress. Knocking out DJ-1 (also known as PARK7), a gene associated with early-onset Parkinson's disease, exacerbated this stress. These results point to a common mechanism underlying mitochondrial oxidant stress in Parkinson's disease and a therapeutic strategy to ameliorate it.
引用
收藏
页码:1414 / 1421
页数:8
相关论文
共 50 条
[1]  
ALBIN RL, 1995, TRENDS NEUROSCI, V18, P63
[2]   The action potential in mammalian central neurons [J].
Bean, Bruce P. .
NATURE REVIEWS NEUROSCIENCE, 2007, 8 (06) :451-465
[3]   Use of antihypertensives and the risk of Parkinson disease [J].
Becker, Claudia ;
Jick, Susan S. ;
Meier, Christoph R. .
NEUROLOGY, 2008, 70 (16) :1438-1444
[4]   Detrimental deletions: mitochondria, aging and Parkinson's disease [J].
Biskup, Saskia ;
Moore, Darren J. .
BIOESSAYS, 2006, 28 (10) :963-967
[5]   The cholinergic system and Parkinson disease [J].
Bohnen, Nicolaas I. ;
Albin, Roger L. .
BEHAVIOURAL BRAIN RESEARCH, 2011, 221 (02) :564-573
[6]   Stages in the development of Parkinson's disease-related pathology [J].
Braak, H ;
Ghebremedhin, E ;
Rüb, U ;
Bratzke, H ;
Del Tredici, K .
CELL AND TISSUE RESEARCH, 2004, 318 (01) :121-134
[7]  
BROWN GC, 1992, BIOCHEM J, V284, P1
[8]   Epidemiology of Parkinson's disease [J].
de Lau, Lonneke M. L. ;
Breteler, Monique M. B. .
LANCET NEUROLOGY, 2006, 5 (06) :525-535
[9]   DISTRIBUTION OF PARVALBUMIN IMMUNOREACTIVITY IN THE CAT BRAIN-STEM [J].
DELEON, M ;
COVENAS, R ;
NARVAEZ, JA ;
AGUIRRE, JA ;
GONZALEZBARON, S .
BRAIN RESEARCH BULLETIN, 1993, 32 (06) :639-646
[10]   Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease [J].
Dickson, Dennis W. ;
Fujishiro, Hiroshige ;
DelleDonne, Anthony ;
Menke, Joshua ;
Ahmed, Zeshan ;
Klos, Kevin J. ;
Josephs, Keith A. ;
Frigerio, Roberta ;
Burnett, Melinda ;
Parisi, Joseph E. ;
Ahlskog, J. Eric .
ACTA NEUROPATHOLOGICA, 2008, 115 (04) :437-444